Literature DB >> 8891520

Preparation and characterization of human recombinant protein 1/Clara cell M(r) 10,000 protein.

R Okutani1, Y Itoh, T Yamada, T Yamaguchi, G Singh, H Yagisawa, T Kawai.   

Abstract

Protein 1, which is identical to human Clara cell M(r) 10(4) protein, is a homodimeric, low molecular mass protein (M(r) 14,000) and an effective inhibitor of phospholipase A2 activity. We have expressed this protein in E. coli and characterized its physiochemical and biological properties. Using a pET expression system, about 1.7 mg of purified recombinant protein 1 was obtained from 250 ml of E. coli culture. The amino-terminal sequence of recombinant protein 1 up to the 20th residue was identical to that of native protein 1 except for an extra methionine at the amino-terminus. On reversed-phase HPLC, recombinant protein 1 eluted at the same retention time as native protein 1. The dose-response curves of recombinant protein 1 and native protein 1 in an enzyme-linked immunosorbent assay for protein 1 were identical. Recombinant protein 1 inhibited both porcine pancreas and cobra venom phospholipase A2 activities. These results indicated that recombinant protein 1 is structurally and biologically identical to native protein 1. We found that recombinant protein 1 also inhibits phosphatidylinositol-specific phospholipase C activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891520     DOI: 10.1515/cclm.1996.34.9.691

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  2 in total

1.  Determination of Clara cell protein urinary elimination as a marker of tubular dysfunction.

Authors:  Ascensión Martín-Granado; Carmen Vázquez-Moncholí; María Isabel Luis-Yanes; Marisela López-Méndez; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

2.  Lung Secretoglobin Scgb1a1 Influences Alveolar Macrophage-Mediated Inflammation and Immunity.

Authors:  Min Xu; Wei Yang; Xuanchuan Wang; Deepak Kumar Nayak
Journal:  Front Immunol       Date:  2020-10-01       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.